BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33268593)

  • 1. Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction.
    Misumi K; Wheeler DS; Aoki Y; Combs MP; Braeuer RR; Higashikubo R; Li W; Kreisel D; Vittal R; Myers J; Lagstein A; Walker NM; Farver CF; Lama VN
    JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33268593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
    Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
    Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mitigating effect of exogenous carbon monoxide on chronic allograft rejection and fibrosis post-lung transplantation.
    Aoki Y; Walker NM; Misumi K; Mimura T; Vittal R; McLinden AP; Fitzgerald L; Combs MP; Lyu D; Osterholzer JJ; Pinsky DJ; Lama VN
    J Heart Lung Transplant; 2023 Mar; 42(3):317-326. PubMed ID: 36522238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histomorphological spectrum of restrictive chronic lung allograft dysfunction and implications for prognosis.
    von der Thüsen JH; Vandermeulen E; Vos R; Weynand B; Verbeken EK; Verleden SE
    Mod Pathol; 2018 May; 31(5):780-790. PubMed ID: 29327719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.
    Angaswamy N; Tiriveedhi V; Sarma NJ; Subramanian V; Klein C; Wellen J; Shenoy S; Chapman WC; Mohanakumar T
    Hum Immunol; 2013 Nov; 74(11):1478-85. PubMed ID: 23876679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel model for dissecting roles of IL-17 in lung transplantation.
    Chen R; Liang F; Chen Q; Xu J; Ding Y
    J Thorac Dis; 2018 Jun; 10(6):3298-3307. PubMed ID: 30069326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
    Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM
    Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction.
    Mineura K; Tanaka S; Goda Y; Terada Y; Yoshizawa A; Umemura K; Sato A; Yamada Y; Yutaka Y; Ohsumi A; Nakajima D; Hamaji M; Mennju T; Kreisel D; Date H
    Am J Transplant; 2024 Jun; 24(6):944-953. PubMed ID: 38403187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.
    Yagisawa T; Tanaka T; Miyairi S; Tanabe K; Dvorina N; Yokoyama WM; Valujskikh A; Baldwin WM; Fairchild RL
    Kidney Int; 2019 Feb; 95(2):350-362. PubMed ID: 30503624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Humoral Immunity during the Pathogenesis of Experimental Chronic Lung Allograft Dysfunction.
    Reichert M; Atanasova S; Petri K; Kampschulte M; Kojonazarov B; Fuchs-Moll G; Krombach GA; Padberg W; Grau V
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPS-induced Airway-centered Inflammation Leading to BOS-like Airway Remodeling Distinct From RAS-like Fibrosis in Rat Lung Transplantation.
    Takahagi A; Sato M; Chen-Yoshikawa TF; Miyamoto E; Saito M; Gochi F; Hamaji M; Yoshizawa A; Terasaki Y; Urushiyama H; Aoyama A; Sonobe M; Date H
    Transplantation; 2020 Jun; 104(6):1150-1158. PubMed ID: 31929420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germinal Center Alloantibody Responses Mediate Progression of Chronic Allograft Injury.
    Chhabra M; Alsughayyir J; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3038. PubMed ID: 30728823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Identification of Chronic Lung Allograft Dysfunction: The Need of Biomarkers.
    Tissot A; Danger R; Claustre J; Magnan A; Brouard S
    Front Immunol; 2019; 10():1681. PubMed ID: 31379869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
    Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin priming prolongs lung allograft survival by promoting immune tolerance.
    Hu H; Zhu X; Joshi S; Lu L; Xia CQ; Patel JM
    PLoS One; 2015; 10(5):e0124705. PubMed ID: 25933390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
    Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
    Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
    Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3039. PubMed ID: 30740108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
    Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?
    Sato M
    Ann Transl Med; 2020 Mar; 8(6):418. PubMed ID: 32355862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.